Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 44 | SFEBES2016 | Next issue

Society for Endocrinology BES 2016

Brighton, UK
07 Nov 2016 - 09 Nov 2016

Card image cap
07 Nov 2016 to 09 Nov 2016 Brighton, UK Further information


Challenges in pituitary disease

ea0044s1.1 | Challenges in pituitary disease | SFEBES2016

How to manage patients with acromegaly and discordant GH and IGF-I results

Trainer Peter

Serum GH and IGF-I levels are closely correlated but discordance between GH and IGF-I levels can occur in patients with acromegaly either as a consequence of biological factors or as an artefact of the means of assessment or definitions of normality.Pegvisomant as a GH receptor antagonist lowers serum IGF-I but, due to negative feedback, increases GH levels. Raloxifene has been shown to lower IGF-I in men and women with acromegaly and oestrogen has been ...

ea0044s1.3 | Challenges in pituitary disease | SFEBES2016

Quality of life in patients with pituitary disease

Karavitaki Niki

Pituitary disease covers a wide spectrum of conditions associated with considerable physical, psychological and cognitive manifestations, a number of which persist even after successful treatment of the pituitary gland disorder.Quality of life (QoL) is defined as ‘the functional effect of an illness and its consequent therapy upon a patient, as perceived by the patient’’. In the last years, the area of QoL in patients with pituitary diseas...